Covid-19 vaccine: Research on at Oxford lab, clinical trial on humans soon

BENGALURU: University of Oxford researchers working in vaccine development effort to prevent Covid-19 have started screening healthy volunteers (aged 18-55) for their upcoming ChAdOx1 
nCoV-19 vaccine trial in the Thames Valley Region.
The vaccine, the university said, is based on an adenovirus vaccine vector and the SARS-CoV-2 spike protein is already in production but won’t be ready for some weeks still.

"The team will enrol healthy volunteers aged between 18 – 55, who, if they pass screening, will be the first humans to test the new vaccine, called ChAdOx1 nCoV-19," the varsity said in a statement.

The trial will provide valuable information on the safety aspects of the vaccine, as well as its ability to generate an immune response against the virus.

Comments

Post a Comment

Popular posts from this blog

Coronavirus cases in India: What is happening? Here's everything you should know

Image
The coronavirus is a large family of viruses that causes illnesses ranging from the common cold to acute respiratory syndromes, but the current virus is a novel strain not seen before. Common symptoms of the novel coronavirus strain include respir... After a spike in covid cases,  India  has put in place strict restrictions on inbound travel. The WHO has also declared it a pandemic after more than 200,000 confirmed cases and over 8,900 deaths in 114 countries. India has confirmed three  coronavirus   deaths so far. After a spike in covid cases,  India  has put in place strict restrictions on inbound travel. The WHO has also declared it a pandemic after more than 200,000 confirmed cases and over 8,900 deaths in 114 countries. India has confirmed three  coronavirus  deaths so far. India has suspended "all existing visas, except diplomatic, official, UN/international organisations, employment, project visas" until April 15. The ...
Read more